Sandy Liebhard

Sandy A. Liebhard, a founding partner at Bernstein Liebhard LLP, has successfully represented plaintiffs in complex litigations for more than 20 years. As dedicated consumer advocates, Mr. Liebhard and his fellow attorneys have taken on some of the largest corporate interest in the nation in cases involving dangerous pharmaceuticals, faulty medical devices and defective consumer products. As an author for RXInuryHelp.com, Mr. Liebhard has written extensively on the litigation involving proton pump inhibitors (Nexium, Prilosec, PrevAcid, etc.) and kidney injuries; Risperdal and gynecomastia; the Bair Hugger forced air warming blanket; talcum powder and ovarian cancer; transvaginal mesh; power morcellators; defective hip implants; and more.

Mr. Liebhard is a 1988 graduate of Brooklyn Law School. He is admitted to the Bar of the State of New York, as well as the United States District Courts for the Southern and Eastern Districts of New York.


Joint Status Report Outlines Progress of Federal Taxotere Hair Loss Lawsuits

Federally-filed Taxotere lawsuits involving the chemotherapy drug’s alleged potential to cause permanent hair loss continue to move forward in the U.S. District Court, Eastern District of Louisiana. The litigation convened its most recent status conference on July 18th.  A day … Continue reading

Gadolinium MRI Contrast Dye Lawsuit Alleges Toxic Effects from MultiHance and OptiMark

A California man has joined the growing litigation over MRI contrast dyes and the risks allegedly associated with gadolinium retention. Plaintiff Alleges Severe Health Consequences from Gadolinium Retention According to a complaint filed in the U.S. District Court, Northern District … Continue reading

IVC Filters Associated with Higher Death Risk Among VTE Patients

Inferior Vena Cava (IVC) filters may not be the best treatment option for patients who suffer from venous thromboembolism, or VTE, according to a new study which suggests a higher risk of 30-day mortality among those who receive the filters. … Continue reading

Diabetes Drug Lawsuit Filings Climb, Following Reinstatement of Pancreatic Cancer Litigation

Hundreds of additional plaintiffs are now pursuing diabetes drug lawsuits, following the reinstatement of pancreatic cancer claims involving Byetta, Victoza, and other incretin mimetics, by an appeals court late last year. Incretin Mimetics and Pancreatic Cancer Byetta and other incretin … Continue reading

Research Suggests Cancer Risk Increases with Chronic Proton Pump Inhibitor Use

Chronic users of Nexium and other proton pump inhibitors may face a higher risk of cancer, according to findings recently published by a team of Swedish researchers. Proton pump inhibitors, including prescription and over-the-counter versions of Nexium, Prilosec, and Prevacid, … Continue reading

Report: SIRVA Cited in Half of New Vaccine Injury Lawsuits

Incidents of SIRVA, or Shoulder Injury Resulting from Vaccine Administration, may be on the rise, as half of all vaccine injury claims filed with the federal government last year involved this painful and potentially debilitating complication. What is SIRVA? SIRVA … Continue reading

Janssen Discontinued Levaquin Production as Concerns Over Fluoroquinolone Side Effects Grow

Johnson & Johnson’s Janssen Pharmaceuticals unit discontinued production of Levaquin in December 2017, amid growing concerns over the serious side effects and complications potentially associated with the use of fluoroquinolone antibiotics. The decision affected both oral and injectable versions of … Continue reading

Colgate-Palmolive Settles Another Talcum Powder Cancer Lawsuit

Colgate-Palmolive has agreed to settle another mesothelioma lawsuit involving the company’s talcum powder products. The agreement to resolve the case was announced yesterday, just before the talcum powder lawsuit was set to go to trial in California Superior Court in … Continue reading

Transvaginal Mesh Complications Lead to Virtual Ban at U.K. Hospitals

Regulators in the U.K. have effectively banned the use of transvaginal mesh in hospitals run by the National Health Services (NHS) in an effort to lessen the risk “life-changing and life-threatening injuries” to women. Decision a Major Victory for U.K. … Continue reading

Florida Tasigna Lawsuit Moves Forward, After Federal Judge Finds Failure-to-Warn Claims Not Preempted

A Florida man who suffered a stroke while taking Tasigna to treat his chronic myeloid leukemia (CML) will be able to pursue his lawsuit against Novartis AG, after a federal judge found that his failure-to-warn claims are not preempted. What … Continue reading

Follow Us

RXInjuryHelp.com on Google+  RXInjuryHelp.com on Facebook  RXInjuryHelp.com on LinkedIn  RXInjuryHelp.com on Twitter  RXInjuryHelp.com on YouTube  RXInjuryHelp.com on Pinterest

Skip to content